Lsl Pharma Group Inc. Logo

Lsl Pharma Group Inc. (LSL)

TSXV

Currency in CAD
0.3000
+0.0050 (+1.69%)

Closed

Oct 8, 2026

Day's Range

0.2950
0.3000

52 wk Range

0.2750
0.5600

Overview - LSL - Lsl Pharma Group Inc.

Key Statistics

Valuation

Enterprise Value

87.01M

P/E (Trailing)

‪17.75‬

Price / Sales (TTM)

‪0.89‬

Price / Book

‪1.70‬

EV / EBITDA

‪-53.91‬

Profitability

Gross Margin

‪11.94%‬

Profit Margin

‪-17.53%‬

Operating Margin

‪-7.53%‬

Return on Assets

‪-3.58%‬

Return on Equity

‪-31.63%‬

Ownership

Shares Outstanding

126.72M

Float

95.70M

Held by Insiders

‪24.63%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪-0.52‬

50-Day Avg

‪0.3364‬

200-Day Avg

‪0.3801‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - LSL - Lsl Pharma Group Inc.

News & Analysis

View all news

Market Cap - LSL - Lsl Pharma Group Inc.

Peers - LSL - Lsl Pharma Group Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on TSXV.

Profile Summary - LSL - Lsl Pharma Group Inc.

About

Lsl Pharma Group Inc. is a prominent enterprise in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of healthcare products. The company's core mission is to enhance patient health and wellness through innovative pharmaceutical solutions. Lsl Pharma Group Inc. operates…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees186
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.